RIGEL PHARMACEUTICALS
Rigel Pharmaceuticals, Inc. (Rigel), is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. The Company has product development programs in inflammatory/autoimmune diseases, such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.
RIGEL PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
1996-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.rigel.com
Total Employee:
101+
Status:
Active
Contact:
650-624-1100
Email Addresses:
[email protected]
Total Funding:
192.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Apache
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Rigel Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Rigel Pharmaceuticals
Alta Partners
Alta Partners investment in Post-IPO Equity - Rigel Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Rigel Pharmaceuticals
MPM Capital
MPM Capital investment in Post-IPO Equity - Rigel Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Post-IPO Equity - Rigel Pharmaceuticals
Official Site Inspections
http://www.rigel.com Semrush global rank: 1.08 M Semrush visits lastest month: 30.65 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Rigel Pharmaceuticals"
ESG :: Rigel Pharmaceuticals, Inc. (RIGL)
At Rigel, our commitment to ESG is integral to our corporate governance. Oversight of our ESG strategy and policies occurs at multiple levels within our organization. The Board of Directors โฆSee details»
Management Team :: Rigel Pharmaceuticals, Inc. (RIGL)
Dean Schorno was appointed as Executive Vice President and Chief Financial Officer (CFO) in May 2018. Mr. Schorno joined Rigel from 23andMe, Inc., the leading consumer genetics and โฆSee details»
Corporate Governance :: Rigel Pharmaceuticals, Inc. (RIGL)
Lapointe offers Rigelโs Board nearly three decades of commercial and financial experience bringing products to market in the areas of medical devices and rare diseases.See details»
Rigel Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The Org
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and โฆSee details»
Investor Relations :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with โฆSee details»
Rigel Pharmaceuticals - Crunchbase Company Profile & Funding
Rigel Pharmaceuticals, Inc. (Rigel), is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory/autoimmune โฆSee details»
Rigel Pharmaceuticals, Inc. (RIGL) - Yahoo Finance Canada
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.See details»
Rigel Pharmaceuticals, Inc. (RIGL) - Yahoo Finance
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.See details»
Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.See details»
Rigel - Crunchbase Company Profile & Funding
Originating from resource-scarce Singapore, Rigel has shown that the progressive spirit of innovation knows no bounds. Pioneering premium restroom solutions that make optimum use โฆSee details»
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is favoured by โฆ
Apr 21, 2023ย ยท To get a sense of who is truly in control of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), it is important to understand the ownership structure of the business. And โฆSee details»
Rigel
RIGEL is a multi-disciplinary consultancy that delivers outcomes to clients in the public and private sectors. We discreetly address and resolve issues of critical and strategic importance affecting โฆSee details»
Rigel Shipping Canada Inc.
Rigel Shipping Canada Inc., established in 1993, operates a fleet of Canadian-flagged oil tankers and is a recognized leader in the Canadian petroleum and petrochemical transportation industry.See details»
Rigel - Wikipedia
Rigel is a blue supergiant star in the constellation of Orion. It has the Bayer designation ฮฒ Orionis, which is Latinized to Beta Orionis and abbreviated Beta Ori or ฮฒ Ori. Rigel is the brightest and โฆSee details»
Financial Results :: Rigel Pharmaceuticals, Inc. (RIGL)
ยฉ 2024 Rigel Pharmaceuticals, Inc. All Rights Reserved. TAVALISSE, TAVLESSE, REZLIDHIA, GAVRETO, RIGEL and the Rigel arc logo are registered trademarks of Rigel ...See details»
Rigel
Smart Living SystemSee details»
Kang and Kodos - Wikipedia
Kang and Kodos Johnson [1] are a duo of fictional recurring characters in the animated television series The Simpsons.Kang is voiced by Harry Shearer and Kodos by Dan Castellaneta.They โฆSee details»
Rigel Reports Fourth Quarter and Full Year 2020 Financial Results โฆ
Mar 2, 2021ย ยท SOUTH SAN FRANCISCO, Calif., March 2, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter โฆSee details»
Rigel: Flexible Multi-Rate Image Processing Hardware - Stanford โฆ
Figure 1: Rigel takes a exible multi-rate architecture based on synchronous dataow and compiles it to efcient FPGA implementations. Our architecture supports pyramid image processing, โฆSee details»
Rigel Reports Second Quarter 2021 Financial Results and Provides ...
SOUTH SAN FRANCISCO, Calif., Aug. 3, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the second quarter ended June 30, 2021, โฆSee details»